These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 28057790)
21. Circulating microRNAs in Cardiovascular Diseases. Orlicka-Płocka M; Gurda D; Fedoruk-Wyszomirska A; Smolarek I; Wyszko E Acta Biochim Pol; 2016; 63(4):725-729. PubMed ID: 27755614 [TBL] [Abstract][Full Text] [Related]
22. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400 [TBL] [Abstract][Full Text] [Related]
23. The relationship between inflammatory and oxidative stress biomarkers, atherosclerosis and rheumatic diseases. Şerban C; Drăgan S Curr Pharm Des; 2014; 20(4):585-600. PubMed ID: 23565633 [TBL] [Abstract][Full Text] [Related]
24. Markers of inflammation are strong predictors of subclinical and clinical atherosclerosis in women with hypertension. Rizzo M; Corrado E; Coppola G; Muratori I; Novo G; Novo S Coron Artery Dis; 2009 Jan; 20(1):15-20. PubMed ID: 19060627 [TBL] [Abstract][Full Text] [Related]
25. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease. Ahluwalia N; Blacher J; Szabo de Edelenyi F; Faure P; Julia C; Hercberg S; Galan P Atherosclerosis; 2013 Jun; 228(2):478-84. PubMed ID: 23582589 [TBL] [Abstract][Full Text] [Related]
27. Cardiovascular disease in patients with inflammatory bowel disease: An issue in no guidelines land. Zuin M; Rigatelli G; Del Favero G; Andreotti AN; Picariello C; Zuliani G; Carraro M; Galasso MP; Roncon L Int J Cardiol; 2016 Nov; 222():984-985. PubMed ID: 27526375 [No Abstract] [Full Text] [Related]
28. Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases. Kondkar AA; Abu-Amero KK Biomed Res Int; 2015; 2015():821823. PubMed ID: 25710029 [TBL] [Abstract][Full Text] [Related]
29. Skin cholesterol: test performance, evaluation of potential determinants and correlation analysis with cardiovascular risk factors and circulating markers of inflammation. Reiter M; Wirth S; Pourazim A; Exner M; Baghestanian M; Rumpold H; Minar E; Bucek RA Vasa; 2006 Aug; 35(3):167-73. PubMed ID: 16941405 [TBL] [Abstract][Full Text] [Related]
30. Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases. Battistoni A; Rubattu S; Volpe M Int J Cardiol; 2012 May; 157(2):160-8. PubMed ID: 21763018 [TBL] [Abstract][Full Text] [Related]
31. Prognostic value of reported chest pain for cardiovascular risk stratification in primary care. Leistner DM; Klotsche J; Palm S; Pieper L; Stalla GK; Lehnert H; Silber S; März W; Wittchen HU; Zeiher AM; Eur J Prev Cardiol; 2014 Jun; 21(6):727-38. PubMed ID: 22739685 [TBL] [Abstract][Full Text] [Related]
37. [Serum albumin and cardiovascular diseases: A comprehensive review of the literature]. Arques S Ann Cardiol Angeiol (Paris); 2018 Apr; 67(2):82-90. PubMed ID: 29544976 [TBL] [Abstract][Full Text] [Related]